SAKAR HEALTHCARE
Back to Income Statement
|
SAKAR HEALTHCARE Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹153 Cr | ₹133 Cr | ₹128 Cr | ₹95 Cr | ₹8,298,024 Cr |
What is the latest Revenue of SAKAR HEALTHCARE ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹153 Cr |
| Mar2024 | ₹133 Cr |
| Mar2023 | ₹128 Cr |
| Mar2022 | ₹95 Cr |
| Mar2021 | ₹8,298,024 Cr |
How is Revenue of SAKAR HEALTHCARE Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹153 Cr | 14.99 | |
| Mar2024 | ₹133 Cr | 4.00 | |
| Mar2023 | ₹128 Cr | 35.35 | |
| Mar2022 | ₹95 Cr | -100.00 | |
| Mar2021 | ₹8,298,024 Cr | - | |
Compare Revenue of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹2,525.4 Cr | -1.8% | 29.9% | 252.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,278.0 Cr | -2.5% | -4.7% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹243,966.0 Cr | -4% | 8.1% | 55.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.3% | 0.2% | 36.6% | Stock Analytics | |
| CIPLA | ₹109,950.0 Cr | -1.7% | -6.1% | -12% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,967.4 Cr | -0.2% | -4.4% | -10.2% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | -1.8% |
29.9% |
252.6% |
| SENSEX | -2.8% |
-5.2% |
-8.4% |
You may also like the below Video Courses